Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 34 Squamous Cell Carcinoma of Head and Neck 22 Uterine Cervical Neoplasms 19 Lung Neoplasms 19 Small Cell Lung Carcinoma 16 Oropharyngeal Neoplasms 14 Ovarian Neoplasms 12 Carcinoma 10 Urinary Bladder Neoplasms 9 Stomach Neoplasms 9 Mouth Neoplasms 9 Laryngeal Neoplasms 9 Fallopian Tube Neoplasms 9 Hypopharyngeal Neoplasms 8 Mesothelioma, Malignant 7 Medulloblastoma 7 Cholangiocarcinoma 7 Breast Neoplasms 7 Adenocarcinoma of Lung 7 Pancreatic Neoplasms 6 Neuroblastoma 6 Nasopharyngeal Carcinoma 6 Gallbladder Neoplasms 6 Ganglioneuroblastoma 5 Brain Neoplasms 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Lymphoid Interstitial Pneumonia 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4

Interventions

pembrolizumab 2 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Neoplasms × Platinum × Clear all

NCT04420884 2026-04-08

iintune-1

Takeda

Phase 1/2 Completed

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡